Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 452 results found. Search for [ coronavirus vaccine developed in India ]

Results 80 to 100 of 452
BusinessToday.In
October 23, 2020
Dr Reddy's Laboratories has been given permission to conduct the trails of Russian COVID-19 vaccine Sputnik V, though, the date and time of the test will be determined by the company


BusinessToday.In
October 23, 2020
Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is expected to be at least 60 per cent effective


PB Jayakumar
October 22, 2020
Serum Institute of India (SII) has teamed up with Merck KGaA, Germany, to develop COVID-19 fighting monoclonal antibodies (mAbs), made by cloning a unique white blood cell to increase immunity and fight diseases, along with drug research driven nonprofit scientific research organization IAVI and Scripps Research


BusinessToday.In
October 22, 2020
Covaxin, the COVID-19 vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has received the approval of Drugs Controller General of India (DCGI's) Expert Committee to start the final phase of trials


PB Jayakumar & Joe C Mathew
October 22, 2020
There is not a single instance in history of a vaccine that has been discontinued


BusinessToday.In
October 22, 2020
Feluda, which claims to combine the accuracy of the PCR test with the accessibility of the antigen kits, uses the gene-editing technique CRISPR-Cas9 that had recently earned inventors Emmanuelle Charpentier and Jennifer Doudna the Nobel Prize


BusinessToday.In
October 22, 2020
Bharat Biotech Phase 3 trials: The volunteers would be given two doses of the experimental vaccine in a gap of 28 days


Rashi Bisaria
New Delhi, October 22, 2020
Flipkart's Big Billion Days sees 55% rise in digital payments, over 150% increase in EMI optionsThe annual festive season sale by Flipkart, The Big Billion Days (TBBD), which concluded on October 21 saw 1.5 times growth in the number of transacting sellers, amongst whom more than 35 per cent saw over thrice the sales compared to last year, said the company in a statement. Even as it added nearly 35 per cent new sellers on its platform, nearly 60 per cent of them were from Tier II and Tier II...


BusinessToday.In
October 22, 2020
AstraZeneca vaccine trials: An AstraZeneca spokesperson, while declining to comment on the volunteer's death, said that there were no concerns that would lead the trials to be paused


BusinessToday.In
October 22, 2020
Notably, Serum Institute of India is working with AstraZeneca and Oxford University to conduct trials and produce their vaccine candidate once it receives the required regulatory approvals


Reuters
October 21, 2020
The IMF said it expects Asia's economy to contract 2.2% this year. That decline is 0.6 of a percentage point larger than its forecast in June, due to sharp slumps in countries like India, the Philippines and Malaysia


BusinessToday.In
October 21, 2020
PM Modi had said that India must not weaken the fight against coronavirus till a COVID-19 vaccine is developed and release for use


BusinessToday.In
October 21, 2020
Coronavirus vaccine news: Britain will help fund trials using a manufactured COVID-19 virus to deliberately infect young healthy volunteers with the hope of accelerating the development of vaccines against it


BusinessToday.In
October 21, 2020
AstraZeneca's large, late-stage U.S. trial has been on hold since Sept. 6, after a participant in the company's UK trial fell ill


BusinessToday.In
October 19, 2020
Presently, there are around 40 different coronavirus vaccines in various stages of human clinical trials, comprising one being developed by Oxford University and AstraZeneca, which is already in an advanced stage of testing


BusinessToday.In
October 19, 2020
Chebrolu's invention is based on in-silico methodology. In this, a lead molecule selectively binds with spike protein of COVID-19. She is now planning to work with scientists who are working tirelessly to find vaccine against COVID-19


BusinessToday.In
October 18, 2020
Coronavirus vaccine: Meanwhile, the Drug Control General of India (DCGI) on Saturday approved Dr Reddy's proposal to conduct clinical trials for Sputnik V in India


PTI
October 17, 2020
The associated lockdowns, restrictions and continued uncertainty have caused investments, trade, and remittance flows to plummet, eroded jobs and human capital, kept children out of school, and pressured food and medical supply chains


Joe C Mathew
October 15, 2020
Civil society groups say there is an inequality of access to critical technologies that are needed to address the pandemic; they want WTO member countries to unequivocally support the adoption of the IP Waiver proposal


Rashi Bisaria
New Delhi, October 15, 2020
COVID-19 vaccine: Bharat Biotech fast-tracks Covaxin's trials, halves Phase 2 test sizeAs part of its effort to fast-track COVID-19 vaccine development, Hyderabad-based Bharat Biotech has cut the size of Phase 2 clinical trials of its indigenous coronavirus vaccine Covaxin by half. The vaccine, which Bharat Biotech is developing in collaboration with the country's apex medical research body - Indian Council of Medical Research (ICMR), will now be tested on 380 healthy volunteers in phase 2 a...


PAGES 5 OF 23  12345